Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Coronary Restenosis HELP
Based on 4,082 articles published since 2008
||||

These are the 4082 published articles about Coronary Restenosis that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline None 2017

Feres, Fausto / Costa, Ricardo A / Siqueira, Dimytri / Costa, J Ribamar / Chamié, Daniel / Staico, Rodolfo / Chaves, Áurea J / Abizaid, Alexandre / Marin-Neto, José Antônio / Rassi, Anis / Botelho, Roberto / Alves, Cláudia Maria Rodrigues / Saad, Jamil Abdalla / Mangione, José A / Lemos, Pedro A / Quadros, Alexandre S / Queiroga, Marcelo A Cartaxo / Cantarelli, Marcelo J C / Figueira, Hélio Roque. ·Instituto Dante Pazzanese de Cardiologia, São Paulo, SP - Brasil. · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Ribeirão Preto, SP - Brasil. · Hospital do Coração Anis Rassi, Goiânia, GO - Brasil. · Instituto do Coração do Triângulo, Uberlândia, MG - Brasil. · Escola Paulista de Medicina, São Paulo, SP - Brasil. · Hospital Felício Rocho, Belo Horizonte, MG - Brasil. · Real e Benemérita Sociedade Portuguesa de Beneficência, São Paulo, SP - Brasil. · Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brasil. · Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, RS - Brasil. · Hospital Santa Paula/Cardiocenter, João Pessoa, PB - Brasil. · Hospital Bandeirantes, São Paulo, SP - Brasil. · Clínica São Vicente, Rio de Janeiro, RJ - Brasil. ·Arq Bras Cardiol · Pubmed #28792984.

ABSTRACT: -- No abstract --

2 Guideline Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. 2014

Cortese, Bernardo / Berti, Sergio / Biondi-Zoccai, Giuseppe / Colombo, Antonio / Limbruno, Ugo / Bedogni, Francesco / Cremonesi, Alberto / Silva, Pedro Leon / Sgueglia, Gregory A / Anonymous3690766. ·Interventional Cardiology, A.O. Fatebenefratelli Milano, Italy. ·Catheter Cardiovasc Interv · Pubmed #23934956.

ABSTRACT: Drug-coated balloons are a new tool for the treatment of patients with coronary artery disease. The main feature of this technology is a rapid and homogenous transfer of an antiproliferative drug (paclitaxel) to the vessel wall just at the time of balloon inflation, when neointimal proliferation, in response to angioplasty, is the highest. Moreover, drug-coated balloons share adjuntive advantages over stents: the absence of permanent scaffold and polymer, the respect of the original coronary anatomy, and limited inflammatory stimuli, thereby allowing for short-term dual antiplatelet therapy. To this day, a lot of devices are available in the market, with limited scientific data for the vast majority of them. Thus, the Italian scientific society of interventional cardiologists GISE decided to coordinate the efforts of a group of reknown experts on the field, in order to obtain a Position Paper on the correct use of drug-coated balloons in all the settings of coronary artery disease, giving a class of indication to each one, based on the clinical evidence. This Position Paper represents a quick reference for operators, investigators, and manufactures to promote the understanding and the correct use of the drug-coated balloon technology in everyday clinical practice.

3 Guideline [SICI-GISE position paper on drug-coated balloon use in the coronary district]. 2013

Cortese, Bernardo / Sgueglia, Gregory A / Berti, Sergio / Biondi-Zoccai, Giuseppe / Colombo, Antonio / Limbruno, Ugo / Bedogni, Francesco / Cremonesi, Alberto / Anonymous1860772. · ·G Ital Cardiol (Rome) · Pubmed #24121894.

ABSTRACT: Drug-coated balloons are a new tool for the treatment of patients with coronary artery disease. The main feature of this technology is a rapid and homogeneous transfer of an antiproliferative drug (paclitaxel) to the vessel wall just at the time of balloon inflation, when neointimal proliferation, in response to angioplasty, is the highest. Moreover, drug-coated balloons share adjunctive advantages over stents: the absence of permanent scaffold and polymer, the respect of the original coronary anatomy, and limited inflammatory stimuli, thereby allowing for short-term dual antiplatelet therapy. At present, a variety of devices are available in the market, with limited scientific data for the vast majority of them. Thus, the Italian Society of Interventional Cardiology (SICI-GISE) decided to coordinate the efforts of a group of renowned experts in this field, in order to produce a position paper on the correct use of drug-coated balloons in all settings of coronary artery disease, giving a class of indication to each one, based on clinical evidence. This position paper represents a quick reference for operators, investigators and manufacturers to promote the understanding and the correct use of the drug-coated balloon technology in everyday clinical practice.

4 Guideline Quantitative angiographic methods for bifurcation lesions: a consensus statement from the European Bifurcation Group. 2009

Lansky, Alexandra / Tuinenburg, Joan / Costa, Marco / Maeng, Micheal / Koning, Gerhard / Popma, Jeffrey / Cristea, Ecatarina / Gavit, Laurence / Costa, Ricardo / Rares, Andrei / Van Es, Gerritt-Ann / Lefevre, Thierry / Reiber, Hans / Louvard, Yves / Morice, Marie-Claude / Anonymous5630617. ·Cardiovascular Research Foundation & Columbia University Medical Center, New York, New York 10022, USA. alansky@crf.org ·Catheter Cardiovasc Interv · Pubmed #19085918.

ABSTRACT: The treatment of bifurcation lesions is complex and increasingly common. A growing number of dedicated bifurcation devices are under clinical evaluation, but no standardized methodology exists. Specifically, the angiographic analysis of bifurcation lesions is not standardized and current QCA packages are not designed for bifurcation lesions. This consensus statement outlines the limitations of conventional QCA in the bifurcation application, and outlines a new standard approach for the analysis and reporting of the angiographic results of the bifurcation lesion allowing for future trial and device comparisons and mechanistic insight into location and modes of treatment failure.

5 Editorial Predictive value of C-reactive protein after drug-eluting stent implantation: an update view. 2018

Montone, Rocco A / Niccoli, Giampaolo. ·Department of Cardiovascular & Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy. ·Future Cardiol · Pubmed #30232900.

ABSTRACT: -- No abstract --

6 Editorial Persistent Inflammatory Activity in Blood Cells and Artery Tissue from Patients with Previous Bare Metal Stent. 2018

Fonseca, Francisco Antonio Helfenstein. ·Universidade Federal de São Paulo (UNIFESP), São Paulo, SP - Brazil. ·Arq Bras Cardiol · Pubmed #30183980.

ABSTRACT: -- No abstract --

7 Editorial Evolving insights into the role of local shear stress in late stent failure from neoatherosclerosis formation and plaque destabilization. 2018

Stone, Peter H / Coskun, Ahmet Umit / Croce, Kevin J. ·Cardiovascular Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: pstone@bwh.harvard.edu. · Mechanical and Industrial Engineering, Northeastern University, Boston, MA, USA. · Cardiovascular Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. ·Int J Cardiol · Pubmed #30126653.

ABSTRACT: -- No abstract --

8 Editorial Drug-eluting balloons: an essential tool for contemporary coronary intervention. 2018

Ribeiro, Henrique B. ·Heart Institute of Sao Paulo, University of Sao Paulo, Sao Paulo, Brazil. ·Coron Artery Dis · Pubmed #30067579.

ABSTRACT: -- No abstract --

9 Editorial Improving Spatial Resolution at CT: Development, Benefits, and Pitfalls. 2018

Wang, Jia / Fleischmann, Dominik. ·From the Department of Environmental Health and Safety (J.W.) and Department of Radiology (D.F.), Stanford University, 480 Oak Rd, Stanford, CA 94305. ·Radiology · Pubmed #29944083.

ABSTRACT: -- No abstract --

10 Editorial Long-term clinical observations for a biofunctionalized stent: Yet to deliver their theoretical benefits. 2018

Nakamura, Kenta / Dean, Larry S. ·Division of Cardiology, Regional Heart Center, University of Washington, Seattle, Washington. · Department of Medicine, Regional Heart Center, University of Washington, Seattle, Washington. ·Catheter Cardiovasc Interv · Pubmed #29894587.

ABSTRACT: Endothelial progenitor cells (EPCs) may allow accelerated and functional endothelialization of stents, theoretically reducing late stent complications as well reducing the duration of DAPT. In a pilot study of 193 patients at high risk of target vessel failure (TVF), the Genous EPC capturing stent (ESC) and TAXUS Liberté paclitaxel-eluting second-generation stent (PES) were similar at 5-years. Events rates appear higher for ESC within the first-year followed by higher rate of complications for PES during years 2-5. A larger randomized multi-center trials powered for non-inferiority of ECS to PES is underway.

11 Editorial Predicting Recurrent Restenosis After Drug-eluting Balloon: A First Step Toward Personalized Treatment. 2018

Piccolo, Raffaele / Kolh, Philippe. ·Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. · Department of Biomedical and Preclinical Sciences, University of Liège, CHU Sart Tilman, Liège, Belgium. Electronic address: philippe.kolh@uliege.be. ·Rev Esp Cardiol (Engl Ed) · Pubmed #29545076.

ABSTRACT: -- No abstract --

12 Editorial Current Status of Rotational Atherectomy in the Drug-Eluting Stent Era. 2018

Uetani, Tadayuki / Amano, Tetsuya. ·Internal Medicine, Uetani Medical Office. · Department of Cardiology, Aichi Medical University. ·Circ J · Pubmed #29515046.

ABSTRACT: -- No abstract --

13 Editorial KISS for in-stent restenosis. 2018

Butman, Samuel. ·Verde Valley Medical Center Cottonwood, AZ. ·Catheter Cardiovasc Interv · Pubmed #29460408.

ABSTRACT: We treat ISR primarily with new DES implantation. DES therapy appears to provide the best protection from TVR and possibly death, as well. Be mindful of occult or other evidence of incomplete stent expansion of the original stent.

14 Editorial What Treatment Should We Dare in Patients With In-Stent Restenosis? 2018

Kastrati, Adnan / Joner, Michael / Kufner, Sebastian. ·Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: kastrati@dhm.mhn.de. · Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. · Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. ·JACC Cardiovasc Interv · Pubmed #29413243.

ABSTRACT: -- No abstract --

15 Editorial Effectiveness of new generation drug-eluting stents in ostial right coronary artery lesions. 2018

De Rosa, Matteo / Santulli, Gaetano. ·Department of Biomedical Advanced Sciences, "Federico II" University, Naples, Italy. · Department of Biomedical Advanced Sciences, "Federico II" University, Naples, Italy; Department of Medicine, Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY, USA. Electronic address: gsantulli@gmail.com. ·Int J Cardiol · Pubmed #29407134.

ABSTRACT: -- No abstract --

16 Editorial Clinical Outcomes After Treatment with ELCA for In-Stent Restenosis of DES. 2018

Nakamura, Fumitaka / Amaki, Toshihiro / Fukino, Keiko. ·Third Department of Internal Medicine, Teikyo University Chiba Medical Center. ·Int Heart J · Pubmed #29375109.

ABSTRACT: -- No abstract --

17 Editorial Controversies in the Cath Lab: Navigating Contemporary Conundrums Before, During and After Intervention. 2018

Geisler, Tobias / Gorog, Diana A. ·Medizinische Klinik III, Department Cardiology and Cardiovascular Disease German Heart Competence Centre University Hospital Tubingen Tubingen, Germany. · Postgraduate Medical School University of Hertfordshire, Hertfordshire, United Kingdom. ·Curr Vasc Pharmacol · Pubmed #29345583.

ABSTRACT: -- No abstract --

18 Editorial Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent? 2018

Parikh, Kinjan H / Kirtane, Ajay J. ·Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, United States. · Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, United States. Electronic address: akirtane@columbia.edu. ·Rev Esp Cardiol (Engl Ed) · Pubmed #29104001.

ABSTRACT: -- No abstract --

19 Editorial CHA 2018

Alfonso, Fernando / Díez-Villanueva, Pablo / Rivero, Fernando. ·1 Department of Cardiology, Hospital Universitario La Princesa, Madrid, Spain. ·Angiology · Pubmed #29092620.

ABSTRACT: -- No abstract --

20 Editorial From the Editor's Desk. 2017

Commerford, P J. ·Editor-in-Chief. Email: Patrick.Commerford@uct.ac.za. ·Cardiovasc J Afr · Pubmed #29297542.

ABSTRACT: -- No abstract --

21 Editorial Functionally Incomplete Re-Endothelialization of Stents and Neoatherosclerosis. 2017

Arbustini, Eloisa / Favalli, Valentina / Narula, Jagat. ·Centre for Inherited Cardiovascular Diseases, IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy. Electronic address: e.arbustini@smatteo.pv.it. · Centre for Inherited Cardiovascular Diseases, IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy. · The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. ·JACC Cardiovasc Interv · Pubmed #29102572.

ABSTRACT: -- No abstract --

22 Editorial Challenges of Stent Restenosis in Superficial Femoral and Popliteal Artery Disease. 2017

Niazi, Khusrow / Tukaye, Deepali N. ·Division of Cardiology, Emory University, Atlanta, Georgia. Electronic address: kniazi@emory.edu. · Division of Cardiology, Jack Stephens Heart Institute, Little Rock, Arkanasas. ·JACC Cardiovasc Interv · Pubmed #29050632.

ABSTRACT: -- No abstract --

23 Editorial The Debut of Sirolimus-Eluting Balloons: The Final Nail in the Coffin for In-Stent Restenosis? 2017

Piccolo, Raffaele. ·Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: Raffaele.Piccolo@insel.ch. ·JACC Cardiovasc Interv · Pubmed #28964761.

ABSTRACT: -- No abstract --

24 Editorial Bioresorbable Vascular Scaffolds Restenosis: Pathophysiology and Predictors. 2017

Alfonso, Fernando / Cuesta, Javier. ·Department of Cardiology, Hospital Universitario de La Princesa, Madrid, Spain. Electronic address: falf@hotmail.com. · Department of Cardiology, Hospital Universitario de La Princesa, Madrid, Spain. ·JACC Cardiovasc Interv · Pubmed #28935074.

ABSTRACT: -- No abstract --

25 Editorial Bioabsorbable Stents: A Solution in Search of a Problem? 2017

Welt, Frederick G P. ·Division of Cardiovascular Medicine, University of Utah Health, Salt Lake City, Utah. Electronic address: fred.welt@hsc.utah.edu. ·JACC Cardiovasc Interv · Pubmed #28866034.

ABSTRACT: -- No abstract --

Next